183 related articles for article (PubMed ID: 19614580)
1. Electrodes modified with lipid membranes to study quinone oxidoreductases.
Weiss SA; Jeuken LJ
Biochem Soc Trans; 2009 Aug; 37(Pt 4):707-12. PubMed ID: 19614580
[TBL] [Abstract][Full Text] [Related]
2. Quinone reduction and redox cycling catalysed by purified rat liver dihydrodiol/3 alpha-hydroxysteroid dehydrogenase.
Klein J; Post K; Seidel A; Frank H; Oesch F; Platt KL
Biochem Pharmacol; 1992 Jul; 44(2):341-9. PubMed ID: 1642648
[TBL] [Abstract][Full Text] [Related]
3. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
[TBL] [Abstract][Full Text] [Related]
4. Identification of NAD(P)H quinone oxidoreductase activity in azoreductases from P. aeruginosa: azoreductases and NAD(P)H quinone oxidoreductases belong to the same FMN-dependent superfamily of enzymes.
Ryan A; Kaplan E; Nebel JC; Polycarpou E; Crescente V; Lowe E; Preston GM; Sim E
PLoS One; 2014; 9(6):e98551. PubMed ID: 24915188
[TBL] [Abstract][Full Text] [Related]
5. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
Newsome JJ; Colucci MA; Hassani M; Beall HD; Moody CJ
Org Biomol Chem; 2007 Nov; 5(22):3665-73. PubMed ID: 17971996
[TBL] [Abstract][Full Text] [Related]
6. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
Colucci MA; Moody CJ; Couch GD
Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
[TBL] [Abstract][Full Text] [Related]
7. Role of NAD(P)H:quinone oxidoreductase encoded by drgA gene in reduction of exogenous quinones in cyanobacterium Synechocystis sp. PCC 6803 cells.
Elanskaya IV; Grivennikova VG; Groshev VV; Kuznetsova GV; Semina ME; Timofeev KN
Biochemistry (Mosc); 2004 Feb; 69(2):137-42. PubMed ID: 15000679
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
[TBL] [Abstract][Full Text] [Related]
9. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO).
Bianchet MA; Faig M; Amzel LM
Methods Enzymol; 2004; 382():144-74. PubMed ID: 15047101
[No Abstract] [Full Text] [Related]
10. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism.
Cadenas E
Biochem Pharmacol; 1995 Jan; 49(2):127-40. PubMed ID: 7530954
[No Abstract] [Full Text] [Related]
11. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
[TBL] [Abstract][Full Text] [Related]
12. The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: a review.
Gutierrez PL
Free Radic Biol Med; 2000 Aug; 29(3-4):263-75. PubMed ID: 11035255
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of the Bacillus subtilis succinate dehydrogenase complex with quinones.
Lemma E; Hägerhäll C; Geisler V; Brandt U; von Jagow G; Kröger A
Biochim Biophys Acta; 1991 Sep; 1059(3):281-5. PubMed ID: 1655027
[TBL] [Abstract][Full Text] [Related]
14. [Participation of the quinone acceptor in the transition of complex I from an inactive to active state].
Maklashina EO; Vinogradov AD
Biokhimiia; 1994 Nov; 59(11):1638-45. PubMed ID: 7873673
[TBL] [Abstract][Full Text] [Related]
15. The protein family of pyruvate:quinone oxidoreductases: Amino acid sequence conservation and taxonomic distribution.
Sousa FM; Fernandes B; Pereira MM
Biochim Biophys Acta Bioenerg; 2023 Apr; 1864(2):148958. PubMed ID: 36758662
[TBL] [Abstract][Full Text] [Related]
16. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
[TBL] [Abstract][Full Text] [Related]
17. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
[TBL] [Abstract][Full Text] [Related]
18. Biophysical studies on agents affecting the state of membrane lipids: biochemical and pharmacological implications.
Lenaz G; Curatola G; Mazzanti L; Parenti-Castelli G
Mol Cell Biochem; 1978 Nov; 22(1):3-32. PubMed ID: 154058
[TBL] [Abstract][Full Text] [Related]
19. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man.
Wermuth B; Platts KL; Seidel A; Oesch F
Biochem Pharmacol; 1986 Apr; 35(8):1277-82. PubMed ID: 3083821
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase.
Joseph P; Jaiswal AK
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8413-7. PubMed ID: 8078896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
